GENEVA, July 2 -- CHONG KUN DANG PHARMACEUTICAL CORP. filed a patent application (KR2025/022115) for “GLP-1 RECEPTOR AGONIST, AND USES THEREOF”. With publication no. WO/2026/135289, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C07D 471/04
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....